GlassScriptPhysician profile
Gregory B Cain
NPI 1528388592
$4,015.88
in general payments reported to CMS, 2019-2025
31 companies · $1,054 in 2025
The $1,054 reported for 2025 was more than what 81% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $953 · 2022: $869 · 2023: $487 · 2024: $654 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,194.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $991.87 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $708.30 | 2021-2025 | |
| Pfizer INC. | $318.82 | 2023-2025 | |
| Lilly USA, LLC | $223.84 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $169.17 | 2021-2025 | Repatha, Repatha, Otezla |
| Otsuka America Pharmaceutical, INC. | $160.85 | 2022-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $141.15 | 2022-2024 | |
| Medtronic, INC. | $129.87 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Acadia Pharmaceuticals INC | $127.09 | 2025 | Nuplazid |
| Exact Sciences Corporation | $98.01 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $91.23 | 2022 | |
| Xeris Pharmaceuticals, INC. | $74.32 | 2022-2024 | Gvoke Hypopen |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $73.00 | 2022-2025 | Caplyta |
| Esperion Therapeutics, INC. | $69.50 | 2021 | |
| Abbott Laboratories | $64.43 | 2022-2024 | Freestyle Libre 3 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $62.64 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $61.98 | 2021-2024 | Airsupra |
| Amarin Pharma, INC. | $54.50 | 2021 | |
| Tactile Systems Technology INC | $54.21 | 2023 | Flexitouch Plus, Entre Plus |
| Antares Pharma, INC. | $44.76 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $40.86 | 2021-2023 | |
| Philips North America LLC | $40.81 | 2024 | (Ck7) Extended Holter |
| Janssen Pharmaceuticals, INC | $33.28 | 2022-2023 | Xarelto |
| Axsome Therapeutics, INC. | $30.27 | 2024 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.37 | 2021 | |
| Intra-Sana Laboratories | $27.28 | 2024-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.26 | 2021-2022 | |
| Optos, INC. | $23.02 | 2021 | |
| Clarus Therapeutics INC. | $19.01 | 2021 | |
| Genentech USA, INC. | $15.46 | 2021 | |
| Convatec INC. | $12.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Cain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.